-
Mashup Score: 14Job Advert - 2 month(s) ago
Skip to main content We’ ve put some small files called cookies on your device to help us make improvements to our site. To improve our site we’ d also like to use cookies which will send information to Google Analytics. You can read more about our cookies before you choose. BETA Your feedback will help us to improve this service. We are looking to appoint a Whole time Consultant Haematologist with a specialist interest in Haemostasis and Thrombosis within Sheffield Teaching Hospitals NHS Foundation
Source: beta.jobs.nhs.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15My gene therapy journey - Medical Independent - 2 month(s) ago
Mr Brian O’Mahony, Chief Executive, Irish Haemophilia Society, recounts his experience of participating in a gene therapy…
Source: www.medicalindependent.ieCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17The evolving landscape of von Willebrand disease diagnosis - 2 month(s) ago
In their review article, O’Donnell et al. 2024 outline previous and existing challenges in the diagnosis of von Willebrand disease (VWD) and describe a potential path forward, given the clinical and phenotypic heterogeneity observed in patients with von Willebrand factor (VWF) levels between 30 and 50 IU/dL. VWD is a complex bleeding disorder characterized by deficiencies in VWF, a protein crucial for blood clotting.
Source: www.jthjournal.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5
This large, randomised, placebo-controlled, double-blind, clinical trial showed no effect of the traditional Chinese medicine herbal compound FYTF-919 on functional recovery, survival, and health-related quality of life in patients with moderate to severe intracerebral haemorrhage. The results reaffirm the need for methodologically rigorous, randomised controlled trials to evaluate the effectiveness of existing therapies, including traditional Chinese medicines that are already in widespread use throughout the world.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 65Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort - 2 month(s) ago
Key PointsEmicizumab provides effective outpatient hemostatic prophylaxis for AHA.Rituximab with concurrent emicizumab seems to be safe and promising for A
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7
Russian Ministry of Health has granted approval to Biocad to initiate a Phase III clinical trial for ANB-002, marking the introduction of the country’s. News GxP News.
Source: gxpnews.netCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study - 2 month(s) ago
Key PointsPatients with cancer are at high risk of clinically relevant bleeding, regardless of anticoagulation use.The occurrence of clinically relevant bl
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice - 2 month(s) ago
Abstract. Adeno-associated virus–based gene therapy (valoctocogene roxaparvovec) is an attractive treatment for hemophilia A. Careful clinical management i
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8
The ISTH (nonprofit) offers a variety of educational programs & events for those who have a scientific interest in thrombosis, hemostasis & vascular biology.
Source: bsky.appCategories: General Medicine News, Hem/OncsTweet-
It is great to see the organisations I closely work with getting BlueSky accounts: ISTH: https://t.co/mYEwPgrlxl EAHAD: https://t.co/IKQ9PPXgYR RPTH: https://t.co/6wJLiU0SAF If you have not looked at BlueSky yet, check it out. It is simple to register, and it is what Twitter/X… https://t.co/2YnTdDd37t
-
-
Mashup Score: 7ProfMakris (@profmakris.bsky.social) - 2 month(s) ago
Emeritus Professor of Haemostasis and Thrombosis in Sheffield, UK. I tweet about thrombosis, hemophilia, COVID-19, medicine, NHS & AI. Opinions are my own.
Source: bsky.appCategories: General Medicine News, Hem/OncsTweet
Are you looking for a permanent post as a consultant in haemostasis and thrombosis in a top department? The Sheffield Haemophilia and Thrombosis Centre has a position available. https://t.co/WkyzJVlNvq